no image available Dickens & Co. "Beyond the Standard: Unlocking Optimal Relief for Carcinoid Syndrome Sufferers" "A groundbreaking study reveals the transformative power of an above-standard dose of octreotide LAR in managing debilitating symptoms" Price: 19.00€